Prevalence and correlates of former injection drug use among young noninjecting heroin users in chicago

Substance Use and Misuse

Volumn 45, Issue 12, 2010, Pages 2000-2025

  Broz, Dita ^a   Ouellet, Lawrence J ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

Heroin; HIV infection; Injection drug use; Noninjecting heroin use; Transitions to injection; Viral hepatitis

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; FEMALE; HEROIN DEPENDENCE; HIGH RISK BEHAVIOR; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTERVIEW; MALE; MULTIVARIATE ANALYSIS; PATIENT SELECTION; PREVALENCE; QUESTIONNAIRE; SUBSTANCE ABUSE; UNITED STATES;

ADOLESCENT; ADULT; CHICAGO; FEMALE; HEROIN DEPENDENCE; HIV INFECTIONS; HIV SEROPOSITIVITY; HUMANS; INTERVIEWS AS TOPIC; MALE; MULTIVARIATE ANALYSIS; PATIENT SELECTION; PREVALENCE; QUESTIONNAIRES; RISK-TAKING; SUBSTANCE ABUSE, INTRAVENOUS;

EID: 77954453848     PISSN: 10826084     EISSN: 15322491     Source Type: Journal    
DOI: 10.3109/10826081003682875     Document Type: Article

References (107)

1. Aceijas, C., Rhodes, T. (2007). Global estimates of prevalence of HCV infection among injecting drug users. International Journal of Drug Policy, 18(5):352-358.
2. Alter, M. J. (2007). Epidemiology of hepatitis C virus infection. World Journal of Gastroenterology, 13(17):2436-2441.
3. Amaro, H., Whitaker, R., Coffman, G., Heeren, T. (1990). Acculturation and marijuana and cocaine use: findings from HHANES 1982-84. American Journal of Public Health, 80(Suppl.):54-60.
4. Andrade, X., Sifaneck, S. J., Neaigus, A. (1999). Dope sniffers in New York City: an ethnography of heroin markets and patterns of use. Journal of Drug Issues, 29(2):271-298.
5. Anthony, J. C., Vlahov, D., Celentano, D. D.,Menon, A. S.,Margolick, J. B., Cohn, S., Nelson, K. E., Polk, B. F. (1991). Self-report interview data for a study of HIV-1 infection among intravenous drug users: description of methods and preliminary evidence on validity. Journal of Drug Issues, 21(4):739-757.
6. Astemborski, J., Vlahov, D., Warren, D., Solomon, L., Nelson, K. E. (1994). The trading of sex for drugs or money and HIV seropositivity among female intravenous drug users. American Journal of Public Health, 84(3):382-387.
7. Boyle, J. M., Brunswick, A. F. (1980). What happened in Harlem? Analysis of a decline in heroin use among a generation unit of urban Black youth. Journal of Drug Issues, 10(1):109-130.
8. Bravo, M. J., Barrio, G., de la Fuente, L., Royuela, L., Domingo, L., Silva, T. (2003). Reasons for selecting an initial route of heroin administration and for subsequent transitions during a severe HIV epidemic. Addiction, 98(6):749-760.
9. Brook, J. S., Cohen, P., Jaeger, L. (1998). Developmental variations in factors related to initial and increased levels of adolescent drug involvement. Journal of Genetic Psychology, 159(2): 179-194.
10. Broz, D., Ouellet, L. J. (2008). Racial and ethnic changes in heroin injection in the United States: implications for the HIV/AIDS epidemic. Drug and Alcohol Dependence, 94:221-233.
11. Carruthers, S., Loxley, W. (2002). Attitudes of novice heroin injectors towards non-injecting routes of administration to prevent the transmission of blood borne viruses. International Journal of Drug Policy, 13:69-74.
12. Casriel, C., Des Jarlais, D. C., Rodriguez, R., Friedman, S. R., Stepherson, B., Khuri, E. (1990). Working with heroin sniffers: clinical issues in preventing drug injection. Journal of Substance Abuse Treatment, 7(1):1-10.
13. CDC. (2005a). A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendations of the advisory committee on immunization practices. Part I: Immunization of infants, children, and adolescents. Morbidity and Mortality Weekly Report, 54(RR16):1-23.
14. CDC. (2005b). HIV/AIDS surveillance report. Cases of HIV infection and AIDS in the United States, 2004, Atlanta, GA: US Department of Health and Human Services, CDC. Accessed: http://www.cdc.gov/hiv/topics/surveillance/resources/ reports/2004report/pdf/2004/ SurveillanceReport.pdf.
15. CDC. (2008). HIV prevalence-United States, 2006. Morbidity and Mortality Weekly Report, 57(39):1073-1076.
16. Chitwood, D. D., Comerford, M., Sanchez, J. (2003). Prevalence and risk factors for HIV among sniffers, short-term injectors, and long-term injectors of heroin. Journal of Psychoactive Drugs, 35(4):445-453.
17. Chitwood, D. D., Comerford, M., Weatherby, N. L. (1998). The initiation of the use of heroin in the age of crack. In J. A. Inciardi & L. D. Harrison, (Eds.), (Heroin in the age of crack cocaine (pp. 51-76). Thousand Oaks, CA: Sage.
18. Ciccarone, D. (2008). Heroin in brown, black and white: structural factors and medical consequences in the US heroin market. International Journal of Drug Policy, 20(3):277-282.
19. Community Epidemiology Work Group. (1998). Epidemiologic trends in drug abuse: volume I, executive summary, December 1997, NIH Pub. No.98-4297. Rockville, MD: National Institute on Drug Abuse.
20. Community EpidemiologyWork Group. (2008). Epidemiologic trends in drug abuse: volume II, June 2007, NIH Pub. No. 08-6200A. Rockville, MD: National Institute on Drug Abuse.
21. Crofts, N., Louie, R., Rosenthal, D., Jolley, D. (1996). The first hit: circumstances surrounding initiation into injecting. Addiction, 91(8):1187-1196.
22. Darke, S., Ross, J., Williamson, A., Mills, K. L., Havard, A., Teesson, M. (2008). Injecting and noninjecting heroin administration: transitions and treatment outcomes across 36 months. Journal of Drug Issues, 2:543-558.
23. Des Jarlais, D. C., Arasteh, K., Perlis, T., Hagan, H., Abdul-Quader, A., Heckathorn, D. D., et al. (2007a). Convergence of HIV seroprevalence among injecting and non-injecting drug users in New York City. AIDS, 21(2):231-235. (Pubitemid 46036932)
24. Des Jarlais, D. C., Arasteh, K., Perlis, T., Hagan, H., Heckathorn, D. D.,McKnight, C., et al. (2007b). The transition from injection to non-injection drug use: long-term outcomes among heroin and cocaine users in New York City. Addiction, 102(5):778-785.
25. Des Jarlais, D. C., Casriel, C., Friedman, S. R., Rosenblum, A. (1992). AIDS and the transition to illicit drug injection-results of a randomized trial prevention program. British Journal of Addiction, 87:493-498.
26. Des Jarlais, D. C., Friedman, S. R., Sotheran, J. L., Wenston, J., Marmor, M., Yancovitz, S. R., Frank, B., Beatrice, S., Mildvan, D. (1994). Continuity and change within an HIV epidemic. Injecting drug users in New York City, 1984 through 1992. The Journal of the American Medical Association, 271(2):121-127.
27. Des Jarlais, D. C., Paone, D., Milliken, J., Turner, C. F., Miller, H., Gribble, J., Shi, Q., Hagan, H., Friedman, S. R. (1999). Audio-computer interviewing to measure risk behaviour for HIV among injecting drug users: a quasi-randomized trial. Lancet, 353(9165):1657-1661.
28. Dowling-Guyer, S., Johnson, M. E., Fisher, D. G., Booth, R., Rhodes, F., Needle, R.,Weatherby, N., Watters, J., Estrada, A. L., Andersen, M., Fleming, D., Williams, M., Deren, S., Kotranski, L. (1994). Reliability of drug users' self-reported HIV risk behaviors and validity of self-reported recent drug use. Assessment, 1(4):383-392.
29. Edlin, B. R., Irwin, K. L., Faruque, S., McCoy, C. B.,Word, C., Serrano, Y., et al. (1994). Intersecting epidemics-crack cocaine use and HIV infection among inner-city young adults. New England Journal of Medicine, 331(21):1422-1427.
30. Estrada, A. L. (1998). Drug use and HIV risks among African-American, Mexican-American, and Puerto Rican drug injectors. Journal of Psychoactive Drugs, 30(3):247-253.
31. Evans, J. L., Hahn, J. A., Page-Shafer, K., Lum, P. J., Stein, E. S., Davidson, P. J., Moss, A. R. (2003). Gender differences in sexual and injection risk behavior among active young injection drug users in San Francisco (the UFO Study). Journal of Urban Health, 80(1):137-146.
32. Fennema, J. S., Van Ameijden, E. J., Van Den Hoek, A., Coutinho, R. A. (1997). Young and recentonset injecting drug users are at higher risk for HIV. Addiction, 92(11):1457-1465.
33. Fisher, J. D., Fisher, W. A. (1992). Changing AIDS-risk behavior. Psychological Bulletin, 111(3):455-474.
34. Fischer, B., Manzoni, P., Rehm, J. (2006). Comparing injecting and non-injecting illicit opioid users in a multisite Canadian sample (OPICAN Cohort). European Addiction Research, 12(4): 230-239. (Pubitemid 44387453)
35. Frajzyngier, V., Neaigus, A., Gyarmathy, V. A., Miller, M., Friedman, S. R. (2007). Gender differences in injection risk behaviors at the first injection episode. Drug and Alcohol Dependence, 89(2-3):145-152.
36. Frank, B. (2000). An overview of heroin trends in New York City: past, present and future. Mount Sinai Journal of Medicine, 67(5-6):340-346.
37. Frank, B., Galea, J. (1993). Current drug use trends in New York City. In Epidemiologic trends in drug abuse, Proceedings of the Community EpidemiologyWork Group, Vol.II, NIH Publication no. 94-3746, Rockville, MD: National Institute on Drug Abuse.
38. French, J. F., Safford, J. (1989). AIDS and intranasal heroin. Lancet, 1(8646):1082.
39. Fuller, C. M., Vlahov, D., Arria, A. M., Ompad, D. C., Garfein, R., Strathdee, S. A. (2001). Factors associated with adolescent initiation of injection drug use. Public Health Reports, 116(Suppl. 1):136-145.
40. Fuller, C. M., Vlahov, D., Ompad, D. C., Shah, N., Arria, A., Strathdee, S. A. (2002). High-risk behaviors associated with transition from illicit non-injection to injection drug use among adolescent and young adult drug users: a case-control study. Drug and Alcohol Dependence, 66(2):189-198.
41. Garfein, R. S., Golub, E. T., Greenberg, A. E., Hagan, H., Hanson, D. L., Hudson, S. M., Kapadia, F., Latka, M. H., Ouellet, L. J., Purcell, D.W., Strathdee, S. A., Thiede, H. (2007). A peer-education intervention to reduce injection risk behaviors for HIV and hepatitis C virus infection in young injection drug users. AIDS, 21(14):1923-1932. (Pubitemid 47329769)
42. Garfein, R. S., Vlahov, D., Galai, N., Doherty, M. C., Nelson, K. E. (1996). Viral infections in shortterm injection drug users: the prevalence of the hepatitis C, hepatitis B, human immunodeficiency, and human T- lymphotropic viruses. American Journal of Public Health, 86(5):655-661.
43. Ghanem, K. G., Hutton, H. E., Zenilman, J. M., Zimba, R., Erbelding, E. J. (2005). Audio computer assisted self interview and face to face interview modes in assessing response bias among STD clinic patients. Sexually Transmitted Infections, 81(5):421-425.
44. Goldstein, M. F., Friedman, S. R., Neaigus, A., Jose, B., Ildefonso, G., Curtis, R. (1995). Self-reports of HIV risk behavior by injecting drug users: are they reliable? Addiction, 90(8):1097-1104.
45. Golub, A. L., Johnson, B. D. (1999). Cohort changes in illegal drug use among arrestees in Manhattan: from the Heroin Injection Generation to the Blunts Generation. Substance Use and Misuse, 34(13):1733-1763.
46. Gossop, M., Darke, S., Griffiths, P., Hando, J., Powis, B., Hall, W., Strang, J. (1995). The severity of dependence scale (SDS): psychometric properties of the SDS in English and Australian samples of heroin, cocaine and amphetamine users. Addiction, 90(5):607-614.
47. Gossop, M., Griffiths, P., Powis, B., Strang, J. (1992). Severity of dependence and route of administration of heroin, cocaine, and amphetamines. British Journal of Addiction, 87:1527-1536.
48. Gossop, M., Griffiths, P., Powis, B., Williamson, S., Strang, J. (1996). Frequency of non-fatal heroin overdose: survey of heroin users recruited in non-clinical settings. BMJ, 313(7054):402.
49. Griffiths, P., Gossop, M., Powis, B., Strang, J. (1994). Transitions in patterns of heroin administration: a study of heroin chasers and heroin injectors. Addiction, 89(3):301-309.
50. Hagan, H., Des Jarlais, D. C., Stern, R., Lelutiu-Weinberger, C., Scheinmann, R., Strauss, S., Flom, P. L. (2007). HCV synthesis project: preliminary analyses of HCV prevalence in relation to age and duration of injection. International Journal of Drug Policy, 18(5):341-351.
51. Heckathorn, D. D. (1997). Respondent-driven sampling: a new approach to the study of hidden populations. Social Problems, 44(2):174-199.
52. Hser, Y.-I., Anglin, M. D., McGlothin, W. (1987). Sex differences in addict careers: 1. Initiation of use. American Journal of Drug and Alcohol Abuse, 13(1-2):33-57.
53. Hughes, P. H., Rieche, O. (1995). Heroin epidemics revisited. Epidemiology Reviews, 17(1):66-73.
54. Hunt, N., Griffiths, P., Southwell, M., Stillwell, G., Strang, J. (1999). Preventing and curtailing injecting drug use: a review of opportunities for developing and delivering 'route transition interventions'. Drug and Alcohol Review, 18:441-451.
55. Hunt, N., Stillwell, G., Taylor, C., Griffiths, P. (1998). Evaluation of a brief intervention to prevent initiation into injecting. Drugs: Education, Prevention & Policy, 5(2):185-194.
56. Irwin, K. L., Edlin, B. R., Faruque, S., McCoy, H. V., Word, C., Serrano, Y., et al. (1996). Crack cocaine smokers who turn to drug injection: characteristics, factors associated with injection, and implications for HIV transmission. Drug and Alcohol Dependence, 42:85-92.
57. Kelley, M. S., Chitwood, D. D. (2004). Effects of drug treatment for heroin sniffers: a protective factor against moving to injection? Social Science and Medicine, 58(10):2083-2092.
58. Kinlock, T. W., Hanlon, T. E., Nurco, D. N. (1998). Heroin use in the United States: history and present developments. In J. A. Inciardi & L. D. Harrison (Eds.), Heroin in the age of crack cocaine (pp. 1-30). Thousand Oaks, CA: Sage.
59. Kleinbaum, D. G.,Klein,M.(2002). Logistic regression: a self-learning text.NewYork, NY: Springer-Verlag
60. Langendam, M.W., van Haastrecht, H. J., van Ameijden, E. J. (1999). The validity of drug users' selfreports in a non-treatment setting: prevalence and predictors of incorrect reporting methadone treatment modalities. International Journal of Epidemiology, 28(3):514-520.
61. Lansky, A., Abdul-Quader, A. S., Cribbin, M., Hall, T., Finlayson, T. J., Garfein, R. S., Lin, L. S., Sullivan, P. S. (2007). Developing an HIV behavioral surveillance system for injecting drug users: the National HIV Behavioral Surveillance System. Public Health Reports, 122(Suppl. 1):48-55. (Pubitemid 47450429)
62. Latkin, C. A. (1998). Outreach in natural settings: the use of peer leaders for HIV prevention among injecting drug users' networks. Public Health Reports, 113(Suppl. 1):151-159.
63. Latkin, C. A., Knowlton, A. R., Sherman, S. (2001). Routes of drug administration, differential affiliation, and lifestyle stability among cocaine and opiate users: implications to HIV prevention. Journal of Substance Abuse, 13(1-2):89-102.
64. Latkin, C., Mandell, W., Vlahov, D., Oziemkowska, M., Celentano, D. D. (1996). The long-term outcome of a personal network-oriented HIV prevention intervention for injection drug users: the SAFE Study. American Journal of Community Psychology, 24(3):341-364.
65. MacDonald, M., Crofts, N., Wodak, A., Kaldor, J. (2001). Transmission of the hepatitis C virus infection. In N. Crofts, G. Dore & S. Locarnini (Eds.), Hepatitis C: an Australian perspective (pp. 209-219). Melbourne, Victoria, Australia: IP Communications.
66. Maxwell, J. C., Spence, R. T. (2005). An exploratory study of inhalers and injectors who used black tar heroin. The Journal of Maintenance in the Addictions, 3(1):61-82.
67. McGregor, C., Darke, S., Ali, R., Christie, P. (1998). Experience of non-fatal overdose among heroin users in Adelaide, Australia: circumstances and risk perceptions. Addiction, 93(5):701-711.
68. McQuillan, G. M., Coleman, P. J., Kruszon-Moran, D., Moyer, L. A., Lambert, S. B., Margolis, H. S. (1999). Prevalence of hepatitis B virus infection in the United States: the National Health and Nutrition Examination Surveys, 1976 through 1994. American Journal of Public Health, 89(1):14-18.
69. Metzger, D. S., Koblin, B., Turner, C., Navaline, H., Valenti, F., Holte, S., Gross, M., Sheon, A., Miller, H., Cooley, P., Seage, G. R., 3rd (2000). Randomized controlled trial of audio computerassisted self-interviewing: utility and acceptability in longitudinal studies. HIVNET Vaccine Preparedness Study Protocol Team. American Journal of Epidemiology, 152(2):99-106.
70. Miller, M. (1999). A model to explain the relationship between sexual abuse and HIV risk among women. AIDS Care, 11(1):3-20.
71. Morningstar, P. J., Chitwood, D. D. (1987). How women and men get cocaine: sex role stereotypes and acquisition patterns. Journal of Psychoactive Drugs, 19:135-142.
72. Neaigus, A., Atillasoy, A., Friedman, S. R., Andrade, X., Miller, M., Ildefonso, G., Des Jarlais, D. C. (1998). Trends in the non-injected use of heroin and factors associated with the transition to injecting. In J. A. Inciardi & L. D. Harrison (Eds.), Heroin in the age of crack cocaine (pp. 131-159). Thousand Oaks, CA: Sage.
73. Neaigus, A., Friedman, S. R., Jose, B., Goldstein, M., Curtis, R., Ildefonso, G., Des Jarlais, D. C. (1996). High-risk personal networks and syringe sharing as risk factors for HIV infection among new drug users. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology, 11:499-509.
74. Neaigus, A., Gyarmathy, V. A., Miller, M., Frajzyngier, V. M., Friedman, S. R., Des Jarlais, D. C. (2006). Transitions to injecting drug use among noninjecting heroin users: social network influence and individual susceptibility. Journal of Acquired Immune Deficiency Syndromes, 41(4):493-503.
75. Neaigus, A., Miller, M., Friedman, S. R., Hagen, D. L., Sifaneck, S. J., Ildefonso, G., Des Jarlais, D. C. (2001). Potential risk factors for the transition to injecting among non-injecting heroin users: a comparison of former injectors and never injectors. Addiction., 96(6):847-860.
76. Nelson, K. E., Galai,N., Safaeian,M., Strathdee, S. A., Celentano, D. D.,Vlahov, D. (2002). Temporal trends in the incidence of human immunodeficiency virus infection and risk behavior among injection drug users in Baltimore, Maryland, 1988-1998. American Journal of Epidemiology, 156(7):641-653.
77. Nicolosi, A., Leite, M. L. C., Musicco, M., Molinari, S., Osella, A., Lazzarin, A. (1992). Parenteral and sexual transmission of human immunodeficiency virus in intravenous drug users: a study of seroconversion. American Journal of Epidemiology, 135(3):225-233.
78. O'Donnell, J. A., Jones, J. P. (1968). Diffusion of the intravenous technique among narcotic addicts in the United States. Journal of Health and Social Behavior, 9(2):120-130.
79. Ouellet, L., Jimenez, A., Coward, A., Haines, L., Wiebel, W. (1995). New users of heroin: the influence of social class, race, and ethnicity on initiation and patterns of use. Paper presented at the 123rd Annual Meeting of the American Public Health Association, San Diego, CA, October 30-November 2.
80. Ouellet, L. J., Jimenez, A. D., Johnson, W. A., Wiebel, W. W. (August 11-13, 1993). Heroin again: new users of heroin in Chicago. Paper presented at the Annual meeting of the Society for the Study of Social Problems, Miami Beach, FL.
81. Ouellet, L. J., Rahimian, A., Wiebel, W. W. (1998). The onset of drug injection among sex partners of injection drug users. AIDS Education and Prevention, 10(4):341-350.
82. Ouellet, L. J., Wiebel, W. W., Jimenez, A. D. (1995). Team research methods for studying intranasal heroin use and its HIV risks. In E. Y. Lambert, R. S. Ashery & R. H. Needle, (Eds.), Research monograph 157: qualitative methods in drug abuse and HIV research (pp. 182-211). Rockville, MD: National Institute on Drug Abuse.
83. Perlis, T. E., Des Jarlais, D. C., Friedman, S. R.,Arasteh,K., Turner, C. F. (2004).Audio-computerized self-interviewing versus face-to-face interviewing for research data collection at drug abuse treatment programs. Addiction, 99(7):885-896.
84. Powis, B., Griffiths, P., Gossop, M., Strang, J. (1996). The differences between male and female drug users: community samples of heroin and cocaine users compared. Substance Use and Misuse, 31(5):529-543.
85. Pugatch, D., Lally, M., Combs, C., Rich, J. D., D'Angelo, L. J., Brown, L. (2003). Intranasal heroin use and HIV prevention: opportunities to intervene. Strategies to Improve the Replicability, Sustainability and Durability of HIV Prevention Interventions: Meeting Proceedings. May 6-7, 2003. Washington, DC: National Institute on Drug Abuse.
86. Roy, E., Haley, N., Leclerc, P., Cedras, L., Blais, L., Boivin, J. F. (2003). Drug injection among street youths in Montreal: predictors of initiation. Journal of Urban Health, 80(1):92-105.
87. Roy, E., Haley, N., Leclerc, P., Cedras, L., Boivin, J. F. (2002). Drug injection among street youth: the first time. Addiction, 97(8):1003-1009.
88. Sanchez, J., Chitwood, D. D., Koo, D. J. (2006). Risk factors associated with the transition from heroin sniffing to heroin injection: a street addict role perspective. Journal of Urban Health, 83(5):896-910.
89. Schoener, E. P., Hopper, J. A., Pierre, J. D. (2002). Injection drug use in North America. Infectious Disease Clinics of North America, 16(3):535-551.
90. Sherman, S. G., Fuller, C. M., Shah, N., Ompad, D. V., Vlahov, D., Strathdee, S. A. (2005). Correlates of initiation of injection drug use among young drug users in Baltimore, Maryland: The need for early intervention. Journal of Psychoactive Drugs, 37(4):437-443.
91. Sherman, S. G., Smith, L., Laney, G., Strathdee, S. A. (2002). Social influences on the transition to injection drug use among young heroin sniffers: a qualitative analysis. International Journal of Drug Policy, 13(2):113-120.
92. Smyth, B., Fan, J., Hser, Y. I. (2006). Life expectancy and productivity loss among narcotics addicts thirty-three years after index treatment. Journal of Addictive Diseases, 25(4):37-47.
93. Strang, J., Griffiths, P., Powis, B., Abbey, J., Gossop, M. (1997). How constant is an individual's route of heroin administration? Data from treatment and non-treatment samples. Drug and Alcohol Dependence, 46(1-2):115-118.
94. Strang, J., Griffiths, P., Powis, B., Gossop, M. (1999). Heroin chasers and heroin injectors: differences observed in a community sample in London, UK. American Journal on Addiction, 8(2):148-160.
95. Strathdee, S. A., Sherman, S. G. (2003). The role of sexual transmission of HIV infection among injection and non-injection drug users. Journal of Urban Health, 80(4 Suppl. 3):iii7-iii14.
96. Swift, W., Maher, L., Sunjic, S. (1999). Transitions between routes of heroin administration: a study of Caucasian and Indochinese heroin users in south-western Sydney, Australia. Addiction, 94(1):71-82.
97. Trace, M., Riley, D., Stimson, G. (2005). UNAIDS&the prevention of HIV infection through injecting drug use, London, UK: Drug Policy Programme, The Beckley Foundation.
98. Turner, C. F., Ku, L., Rogers, S.M., Lindberg, L. D., Pleck, J. H., Sonenstein, F. L. (1998). Adolescent sexual behavior, drug use, and violence: increased reporting with computer survey technology. Science, 280(5365):867-873.
99. van Ameijden, E. J., van den Hoek, J. A., Hartgers, C., Coutinho, R. A. (1994). Risk factors for the transition from noninjection to injection drug use and accompanying AIDS risk behavior in a cohort of drug users. American Journal of Epidemiology, 139(12):1153-1163.
100. Vlahov, D., Munoz, A., Anthony, J. C., Cohn, S., Celentano, D. D., Nelson, K. E. (1990). Association of drug injection patterns with antibody to human immunodeficiency virus type 1 among intravenous drug users in Baltimore, Maryland. American Journal of Epidemiology, 132:847-856.
101. Vlahov, D., Wang, C., Ompad, D., Fuller, C. M., Caceres, W., Ouellet, L., Kerndt, P., Jarlais, D. C., Garfein, R. S. (2008). Mortality risk among recent-onset injection drug users in five U.S. cities. Substance Use and Misuse, 43(3-4):413-428.
102. Warner-Smith, M., Darke, S., Lynskey, M., Hall, W. (2001). Heroin overdose: causes and consequences. Addiction, 96(8):1113-1125.
103. Watkins, S. C. (2006). Hip hop matters: politics, pop culture, and the struggle for the soul of the movement. Boston, MA: Beacon.
104. World Health Organization. (2000). Hepatitis B-fact sheet N204. Retrieved June 15, 2009, from http://www.who.int/mediacentre/factsheets/fs204/en/.
105. World Health Organization. (2007). Hepatitis C-initiative for vaccine research. Retrieved November 13, 2007, from http://www.who.int/immunization/ topics/hepatitis c/en/.
106. Witteveen, E., Van Ameijden, E. J., Schippers, G. M. (2006). Motives for and against injecting drug use among young adults in Amsterdam: qualitative findings and considerations for disease prevention. Substance Use and Misuse, 41(6-7):1001-1016.
107. Zimmerman, M., Sheeran, T., Chelminski, I., Young, D. (2004). Screening for psychiatric disorders in outpatients with DSM-IV substance use disorders. Journal of Substance Abuse Treatment, 26(3):181-188.